Novo Nordisk

HQ - New York City,New York, United States

Overview

About Novo

Founded in	1923	Ownership	Private
India Employee count	1k-5k	Global Employee count	10k-50k
Headquarters	New York City,New York, United States	Office Locations	Not Available
CEO	Lars Fruergaard Jorgensen	Founders	Not Available
Type of Company	Foreign MNC	Nature of Business	B2B
Company Email ID	Not Available	Website	novonordisk.com

Founded In	1923
Ownership	Private
India Employee Count	1k-5k
Global Employee Count	10k-50k
Headquarters	New York City,New York, United States
Office Locations	Not Available
CEO	Lars Fruergaard Jorgensen
Founders	Not Available
Type Of Company	Foreign MNC
Nature Of Business	B2B
Company Email ID	Not Available
Website	novonordisk.com

Novo Nordisk is a global healthcare company headquartered in Denmark, with a prominent focus on diabetes care. Founded in 1923, it has grown into a leader in the pharmaceutical industry, also providing treatments for other serious chronic conditions such as hemophilia, growth hormone-related disorders, and obesity.

The company is renowned for its innovations in the field of insulin and diabetes care technology, including insulin pens and newer forms of injectable and oral therapies. Novo Nordisk is committed to a patient-centered approach and actively engages in sustainability efforts, particularly in reducing its environmental impact. Additionally, Novo Nordisk plays a significant role in global health initiatives, aiming to improve access to diabetes care in under-resourced areas around the world.